Pfizer Pays Oregon $3.34M To Settle Unlawful Trade Practice Probe For 2 Drugs

Pfizer Pays Oregon $3.34M To Settle Unlawful Trade Practice Probe For 2 Drugs

SALEM, Ore. - Pfizer Inc. has agreed to pay $3.34 million to settle an investigation by Oregon into the company's promotion and marketing practices of its antibiotic Zyvox and its anticonvulsant drug Lyrica, the state Justice Department announced March 20 (In The Matter Of: Pfizer Inc., No. n/a, Ore. Cir., Marion Co.).

Lexis.com subscribers may access Personal Injury  and Products Liability resources on Lexis.com. Mealey's subscribers may search Mealey's Litigation Reports by Practice Area.

Additional Products Liability resources including Emerging Issues Analysis are available in the LexisNexis Store.

 

Find full version on lexis Advance®
Access this news story on lexis.com®